Details for Patent: 7,709,517
Which drugs does patent 7,709,517 protect, and when does it expire?
Patent 7,709,517 protects XTANDI and is included in two NDAs.
This patent has one hundred and forty-one patent family members in twenty-eight countries.
Summary for Patent: 7,709,517
| Title: | Diarylhydantoin compounds |
| Abstract: | The present invention relates to diarylhydantoin compounds, including diarylthiohydantoins, and methods for synthesizing them and using them in the treatment of hormone refractory prostate cancer. |
| Inventor(s): | Charles L. Sawyers, Michael E. Jung, Charlie D. Chen, Samedy Ouk, Derek Welsbie, Chris Tran, John Wongvipat, Dongwon Yoo |
| Assignee: | University of California , University of California San Diego UCSD |
| Application Number: | US11/433,829 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,709,517 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 7,709,517
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astellas | XTANDI | enzalutamide | CAPSULE;ORAL | 203415-001 | Aug 31, 2012 | RX | Yes | Yes | 7,709,517 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| Astellas | XTANDI | enzalutamide | TABLET;ORAL | 213674-001 | Aug 4, 2020 | AB | RX | Yes | No | 7,709,517 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Astellas | XTANDI | enzalutamide | TABLET;ORAL | 213674-002 | Aug 4, 2020 | AB | RX | Yes | Yes | 7,709,517 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,709,517
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1893196 | ⤷ Start Trial | C300632 | Netherlands | ⤷ Start Trial |
| European Patent Office | 1893196 | ⤷ Start Trial | CA 2013 00065 | Denmark | ⤷ Start Trial |
| European Patent Office | 1893196 | ⤷ Start Trial | PA2013029 | Lithuania | ⤷ Start Trial |
| European Patent Office | 1893196 | ⤷ Start Trial | 1390060-0 | Sweden | ⤷ Start Trial |
| European Patent Office | 1893196 | ⤷ Start Trial | C20130036 00106 | Estonia | ⤷ Start Trial |
| European Patent Office | 1893196 | ⤷ Start Trial | 169 50005-2013 | Slovakia | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
